Urea Kinetics and Intermittent Dialysis Prescription in Small Animals

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 1, 2011, Pages 193-225

  Cowgill, Larry D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dpKt V; eKt V; spKt V; stdKt V; Hemodialysis; Kt V; Urea clearance; Urea generation

Indexed keywords

BICARBONATE; UREA;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; BICARBONATE BLOOD LEVEL; BLOOD FLOW VELOCITY; CARBAMOYLATION; CLINICAL FEATURE; FLUID BALANCE; HEMODIALYSIS; HYPOTENSION; HYPOVOLEMIA; KIDNEY CLEARANCE; KIDNEY FUNCTION; MEMBRANE PERMEABILITY; METABOLIC ACIDOSIS; MORTALITY; NITROGEN METABOLISM; NONHUMAN; ONCOTIC PRESSURE; OXYGEN SATURATION; PROTEIN DEGRADATION; PROTEIN METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW; SAFETY; SYMPTOMATOLOGY; TEMPERATURE; TREATMENT INDICATION; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; KIDNEY FAILURE, CHRONIC; KINETICS; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; UREA; UREMIA;

ANIMALIA;

EID: 78651508523     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2010.12.002     Document Type: Review

References (133)

1. Cowgill L.D., Elliott D.A. Hemodialysis. Fluid therapy in small animal practice 2000, 528-547. WB Saunders, Philadelphia. S.P. DiBartola (Ed.).
2. Cowgill L.D., Francey T. Acute uremia. Textbook of veterinary internal medicine: diseases of the dog and cat 2004, 1731-1751. WB Saunders, Philadelphia. S.J. Ettinger, E.C. Feldman (Eds.).
3. Cowgill L.D., Langston C.E. Role of hemodialysis in the management of dogs and cats with renal failure. Vet Clin North Am Small Anim Pract 1996, 26:1347-1378.
4. Langston C.E., Cowgill L.D., Spano J.A. Applications and outcome of hemodialysis in cats: a review of 29 cases. J Vet Intern Med 1997, 11:348-355.
5. Cowgill L.D., Francey T. Hemodialysis. Fluid therapy in small animal practice 2006, 650-677. Elsevier, St Louis (MO). S.P. DiBartola (Ed.).
6. ICowgill LD, Langston CE. History of hemodialysis in dogs and companion animals. In: TS Ing, MA Rahman, CM Kjellstrand, editors. Dialysis: history, development and promise. Singapore: World Scientific Publishing Company, in press.
7. Cowgill LD, Francey T. Hemodialysis and extracorporeal blood purification. In: DiBartola SP, editor. Fluid therapy in small animal practice. 4th edition. St Louis (MO): Elsevier, in press.
8. Fischer J.R., Pantaleo V., Francey T., et al. Veterinary hemodialysis: advances in management and technology. Vet Clin North Am Small Anim Pract 2004, 34:935-967. vi-vii.
9. Winchester J.F. Dialysis and hemoperfusion in poisoning. Adv Ren Replace Ther 2002, 9:26-30.
10. Smith J.P., Chang I.J. Extracorporeal treatment of poisoning. Brenner and Rector's The Kidney 2008, 2081-2102. Saunders/Elsevier, Philadelphia. 8th Edition. B.M. Brenner (Ed.).
11. Scott N.E., Francey T., Jandrye K. Baclofen intoxication in a dog successfully treated with hemodialysis and hemoperfusion coupled with intensive supportive care. J Vet Emerg Crit Care 2007, 17:191-196.
12. Vanholder R., De Smet R., Glorieux G., et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943.
13. Vanholder R., Van Laecke S. Glorieux G. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?. J Nephrol 2008, 21(2):146-160.
14. Vanholder R., Baurmeister U., Brunet P., et al. European Uremic Toxin Work Group. A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008, 19(5):863-870.
15. Raff A.C., Meyer T.W., Hostetter T.H. New insights into uremic toxicity. Curr Opin Nephrol Hypertens 2008, 17(6):560-565.
16. Depner T.A. Uremic toxicity: urea and beyond. Semin Dial 2001, 14:246-251.
17. Vanholder R., Glorieux G., De Smet R., et al. New insights in uremic toxins. Kidney Int 2003, 63:S6-S10.
18. Vanholder R., Glorieux G., De Smet R., et al. Low water-soluble uremic toxins. Adv Ren Replace Ther 2003, 10:257-269.
19. Vanholder R., Glorieux G., Van Biesen W. Advantages of new hemodialysis membranes and equipment. Nephron Clin Pract 2010, 114(3):c165-c172.
20. Held P.J., Port F.K., Wolfe R.A., et al. The dose of hemodialysis and patient mortality. Kidney Int 1996, 50:550-556.
21. Lowrie E.G., Laird N.M., Parker T.F., et al. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981, 305:1176-1181.
22. Owen W.F., Lew N.L., Liu Y., et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329:1001-1006.
23. Parker T.F., Husni L., Huang W., et al. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994, 23:670-680.
24. Henle T., Miyata T. Advanced glycation end products in uremia. Adv Ren Replace Ther 2003, 10:321-331.
25. Herget-Rosenthal S., Glorieux G., Jankowski J., et al. Uremic toxins in acute kidney injury. Semin Dial 2009, 22(4):445-448.
26. Johnson W.J., Hagge W.W., Wagoner R.D., et al. Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 1972, 47:21-29.
27. Gotch F.A. Evolution of the single-pool urea kinetic model. Semin Dial 2001, 14:252-256.
28. Suri R.S., Depner T., Lindsay R.M. Dialysis prescription and dose monitoring in frequent hemodialysis. Contrib Nephrol 2004, 145:75-88.
29. Depner T.A., Bhat A. Quantifying daily hemodialysis. Semin Dial 2004, 17(2):79-84.
30. Depner T.A. Hemodialysis adequacy: basic essentials and practical points for the nephrologist in training. Hemodial Int 2005, 9(3):241-254.
31. Hemodialysis Adequacy 2006 Work Group Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006, 48(Suppl 1):S2-S90.
32. Vanholder R.C., Glorieux G.L., De Smet R.V. Uremic toxins: removal with different therapies. Hemodial Int 2003, 7:162-167.
33. Sargent J.A., Gotch F.A. Principles and biophysics of dialysis. Replacement of renal function by dialysis: a textbook of dialysis 1989, 87-143. Kluwer Academic Publishers, Boston. J.F. Maher (Ed.).
34. Eknoyan G., Beck G.J., Cheung A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002, 347:2010-2019.
35. Winchester J.F., Audia P.F. Extracorporeal strategies for the removal of middle molecules. Semin Dial 2006, 19(2):110-114.
36. McFarlane P.A. More of the same: Improving outcomes through intensive hemodialysis. Semin Dial 2009, 22(6):598-602.
37. Yeun J.Y., Depner T.A. Complications related to inadequate delivered dose: recognition and management in acute and chronic dialysis. Complications of dialysis 2000, 89-115. Marcel Dekker, Inc, New York. N. Lameire, R.L. Mehta (Eds.).
38. Goldfarb-Rumyantzev A.S., Cheung A.K., Leypoldt J.K. Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis. Am J Kidney Dis 2002, 40(6):1211-1218.
39. Eloot S., Van Biesen W., Dhondt A., et al. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2008, 73(6):765-770.
40. Flanigan M.J. Role of sodium in hemodialysis. Kidney Int Suppl 2000, 76:S72-S78.
41. Stiller S., Bonnie-Schorn E., Grassmann A., et al. A critical review of sodium profiling for hemodialysis. Semin Dial 2001, 14:337-347.
42. Brummelhuis W.J., van Geest R.J., van Schelven L.J., et al. Sodium profiling, but not cool dialysate, increases the absolute plasma refill rate during hemodialysis. ASAIO J 2009, 55(6):575-580.
43. Phipps L.M., Harris D.C. Review: modeling the dialysate. Nephrology (Carlton) 2010, 15(4):393-398.
44. Al-Hilali N., Al-Humoud H.M., Ninan V.T., et al. Profiled hemodialysis reduces intradialytic symptoms. Transplant Proc 2004, 36:1827-1828.
45. Coli L., Ursino M., Donati G., et al. Clinical application of sodium profiling in the treatment of intradialytic hypotension. Int J Artif Organs 2003, 26:715-722.
46. Sherman R.A. Modifying the dialysis prescription to reduce intradialytic hypotension. Am J Kidney Dis 2001, 38:S18-S25.
47. Song J.H., Park G.H., Lee S.Y., et al. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 2005, 16:237-246.
48. Zhou Y.L., Liu H.L., Duan X.F., et al. Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension. Nephrol Dial Transplant 2006, 21(11):3231-3237.
49. De Nicola L., Bellizzi V., Minutolo R., et al. Effect of dialysate sodium concentration on interdialytic increase of potassium. J Am Soc Nephrol 2000, 11:2337-2343.
50. Depner T.A., Ing T.S. Toxic fluid flux?. Am J Kidney Dis 2010, 56(1):1-4.
51. Redaelli B., Bonoldi G., Di Filippo G., et al. Behaviour of potassium removal in different dialytic schedules. Nephrol Dial Transplant 1998, 13(Suppl 6):35-38.
52. Locatelli F., Covic A., Chazot C., et al. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 2004, 19:785-796.
53. Redaelli B. Electrolyte modeling in haemodialysis-potassium. Nephrol Dial Transplant 1996, 11(Suppl 2):39-41.
54. Karnik J.A., Young B.S., Lew N.L., et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001, 60(1):350-357.
55. Arieff A.I. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994, 45:629-635.
56. Arieff A.I., Lazarowitz V.C., Guisado R. Experimental dialysis disequilibrium syndrome: prevention with glycerol. Kidney Int 1978, 14:270-278.
57. Feriani M. Behaviour of acid-base control with different dialysis schedules. Nephrol Dial Transplant 1998, 13(Suppl 6):62-65.
58. Polzin D.J. Chronic Kidney Disease. Textbook of Veterinary Internal Medicine 2010, 1990-2020. Saunders Elsevier, Philadephia. S.J. Ettinger, C.E. Feldman (Eds.).
59. Cowgill LD, Langston CE. Acute Kidney Injury. In: Bartges J, Polzin D, editors. Nephrology and Urology of Small Animals. Wiley-Blackwell, in press.
60. Langston C.E. Acute Uremia. Textbook of Veterinary Internal Medicine 2010, 1969-1984. Saunders Elsevier, Philadephia. S.J. Ettinger, C.E. Feldman (Eds.).
61. Spalding E.M., Chamney P.W., Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 2002, 61(2):655-667.
62. Messa P., Gropuzzo M., Cleva M., et al. Behaviour of phosphate removal with different dialysis schedules. Nephrol Dial Transplant 1998, 13(Suppl 6):43-48.
63. Kuhlmann M.K. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif 2010, 29(2):137-144.
64. Chow M.T., Di Silvestro V.A., Yung C.Y., et al. Treatment of acute methanol intoxication with hemodialysis using an ethanol-enriched, bicarbonate-based dialysate. Am J Kidney Dis 1997, 30:568-570.
65. Noghnogh A.A., Reid R.W., Nawab Z.M., et al. Preparation of ethanol-enriched, bicarbonate-based hemodialysates. Artif Organs 1999, 23:208-209.
66. Locatelli F., Buoncristiani U., Canaud B., et al. Haemodialysis with on-line monitoring equipment: tools or toys?. Nephrol Dial Transplant 2005, 20:22-33.
67. Maggiore Q. Isothermic dialysis for hypotension-prone patients. Semin Dial 2002, 15:187-190.
68. Maggiore Q., Pizzarelli F., Santoro A., et al. The effects of control of thermal balance on vascular stability in hemodialysis patients: results of the European randomized clinical trial. Am J Kidney Dis 2002, 40:280-290.
69. Selby N.M., McIntyre C.W. How should dialysis fluid be individualized for the chronic hemodialysis patient? Temperature. Semin Dial 2008, 21(3):229-231.
70. Chesterton L.J., Selby N.M., Burton J.O., et al. Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 2009, 13(2):189-196.
71. van der Sande F.M., Wystrychowski G., Kooman J.P., et al. Control of core temperature and blood pressure stability during hemodialysis. Clin J Am Soc Nephrol 2009, 4(1):93-98.
72. Rosales L.M., Schneditz D., Morris A.T., et al. Isothermic hemodialysis and ultrafiltration. Am J Kidney Dis 2000, 36:353-361.
73. Pergola P.E., Habiba N.M., Johnson J.M. Body temperature regulation during hemodialysis in long-term patients: is it time to change dialysate temperature prescription?. Am J Kidney Dis 2004, 44:155-165.
74. Suranyi M., Chow J.S. Review: anticoagulation for haemodialysis. Nephrology (Carlton) 2010, 15(4):386-392.
75. Depner T. Benefits of more frequent dialysis: lower TAC at the same Kt/V. Nephrol Dial Transplant 1998, 13:20-24.
76. Suri R., Depner T.A., Blake P.G., et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003, 42:42-48.
77. Ishibe S., Peixoto A.J. Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice. Semin Dial 2004, 17:37-43.
78. Jaeger J.Q., Mehta R.L. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999, 10:392-403.
79. Lambie S.H., McIntyre C.W. Developments in online monitoring of haemodialysis patients: towards global assessment of dialysis adequacy. Curr Opin Nephrol Hypertens 2003, 12:633-638.
80. Schroeder K.L., Sallustio J.E., Ross E.A. Continuous haematocrit monitoring during intradialytic hypotension: precipitous decline in plasma refill rates. Nephrol Dial Transplant 2004, 19:652-656.
81. Zhu F., Kuhlmann M.K., Sarkar S., et al. Adjustment of dry weight in hemodialysis patients using intradialytic continuous multifrequency bioimpedance of the calf. Int J Artif Organs 2004, 27:104-109.
82. Zhu F., Sarkar S., Kaitwatcharachai C., et al. Methods and reproducibility of measurement of resistivity in the calf using regional bioimpedance analysis. Blood Purif 2003, 21:131-136.
83. Steuer R.R., Bell D.A., Barrett L.L. Optical measurement of hematocrit and other biological constituents in renal therapy. Adv Ren Replace Ther 1999, 6:217-224.
84. Agostoni P.G., Marenzi G.C. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001, 96:183-189.
85. Marenzi G., Lauri G., Grazi M., et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001, 38:963-968.
86. Ronco C., Ricci Z., Brendolan A., et al. Ultrafiltration in patients with hypervolemia and congestive heart failure. Blood Purif 2004, 22:150-163.
87. Sheppard R., Panyon J., Pohwani A.L., et al. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004, 10:380-383.
88. Ronco C., Giomarelli P. Current and future role of ultrafiltration in CRS. Heart Fail Rev October 23, 2010, 10. [online].
89. Kazory A., Ross E.A. Emerging therapies for heart failure: renal mechanisms and effects. Heart Fail Rev August 31, 2010, 10. [online].
90. Wertman B.M., Gura V., Schwarz E.R. Ultrafiltration for the management of acute decompensated heart failure. J Card Fail 2008, 14(9):754-759.
91. Holubek W.J., Hoffman R.S., Goldfarb D.S., et al. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008, 74(10):1327-1334.
92. Borkan S.C. Extracorporeal therapies for acute intoxications. Crit Care Clin 2002, 18(2):393-420.
93. Tyagi P.K., Winchester J.F., Feinfeld D.A. Extracorporeal removal of toxins. Kidney Int 2008, 74(10):1231-1233.
94. Winchester J.F., Harbord N.B., Rosen H. Management of poisonings: core curriculum 2010. Am J Kidney Dis 2010, 56(4):788-800.
95. Bayliss G. Dialysis in the poisoned patient. Hemodial Int 2010, 14(2):158-167.
96. Shalkham A.S., Kirrane B.M., Hoffman R.S., et al. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 2006, 48(2):239-241.
97. Chandy T., Sharma C.P. Activated charcoal microcapsules and their applications. J Biomater Appl 1998, 13(2):128-157.
98. Segev G., Kass P.H., Francey T., et al. A novel clinical scoring system for outcome prediction in dogs with acute kidney injury managed by hemodialysis. J Vet Intern Med 2008, 22(2):301-308.
99. Waniewski J., Debowska M., Lindholm B. Theoretical and numerical analysis of different adequacy indices for hemodialysis and peritoneal dialysis. Blood Purif 2006, 24(4):355-366.
100. Sherman R.A., Cody R.P., Rogers M.E., et al. Accuracy of the urea reduction ratio in predicting dialysis delivery. Kidney Int 1995, 47:319-321.
101. Lowrie E., Lew N. The urea reduction ratio (URR): a simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol 1991, 12:11-20.
102. Daugirdas J.T. The post:pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs 1989, 12:411-419.
103. Gotch F.A. Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens?. Semin Dial 2001, 14:15-17.
104. Lopot F., Valek A. Time-averaged concentration-time-averaged deviation: a new concept in mathematical assessment of dialysis adequacy. Nephrol Dial Transplant 1988, 3:846-848.
105. Sargent J.A., Lowrie E.G. Which mathematical model to study uremic toxicity? National Cooperative Dialysis Study. Clin Nephrol 1982, 17:303-314.
106. Lowrie E.G., Teehan B.P. Principles of prescribing dialysis therapy: implementing recommendations from the National Cooperative Dialysis Study. Kidney Int Suppl 1983, S113-S122.
107. Levine J., Bernard D.B. The role of urea kinetic modeling, TACurea, and Kt/V in achieving optimal dialysis: a critical reappraisal. Am J Kidney Dis 1990, 15:285-301.
108. Shinaberger J.H. Quantitation of dialysis: historical perspective. Semin Dial 2001, 14:238-245.
109. Sargent J.A., Gotch F.A. Mathematic modeling of dialysis therapy. Kidney Int Suppl 1980, 10:S2-S10. 1980.
110. Schneditz D., Daugirdas J.T. Compartment effects in hemodialysis. Semin Dial 2001, 14:271-277.
111. Smye S.W., Tattersall J.E., Will E.J. Modeling the postdialysis rebound: the reconciliation of current formulas. ASAIO J 1999, 45:562-567.
112. Daugirdas J.T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993, 4(5):1205-1213.
113. Mercadal L., Ridel C., Petitclerc T. Ionic dialysance: principle and review of its clinical relevance for quantification of hemodialysis efficiency. Hemodial Int 2005, 9(2):111-119.
114. Moret K., Beerenhout C.H., van den Wall Bake A.W., et al. Ionic dialysance and the assessment of Kt/V: the influence of different estimates of V on method agreement. Nephrol Dial Transplant 2007, 22(8):2276-2282.
115. Gotch F.A., Panlilio F.M., Buyaki R.A., et al. Mechanisms determining the ratio of conductivity clearance to urea clearance. Kidney Int Suppl 2004, (89):S3-S24.
116. Carl D.E., Feldman G. Estimating dialysis adequacy using ionic dialysance. Ren Fail 2008, 30(5):491-498.
117. Polaschegg H.D. Automatic, noninvasive intradialytic clearance measurement. Int J Artif Organs 1993, 16:185-191.
118. Petitclerc T. Festschrift for Professor Claude Jacobs. Recent developments in conductivity monitoring of haemodialysis session. Nephrol Dial Transplant 1999, 14:2607-2613.
119. Kuhlmann U., Goldau R., Samadi N., et al. Accuracy and safety of online clearance monitoring based on conductivity variation. Nephrol Dial Transplant 2001, 16:1053-1058.
120. Di Filippo S., Manzoni C., Andrulli S., et al. Ionic dialysance allows an adequate estimate of urea distribution volume in hemodialysis patients. Kidney Int 2004, 66:786-791.
121. Di Filippo S., Manzoni C., Andrulli S., et al. How to determine ionic dialysance for the online assessment of delivered dialysis dose. Kidney Int 2001, 59:774-782.
122. Chesterton L.J., Priestman W.S., Lambie S.H., et al. Continuous online monitoring of ionic dialysance allows modification of delivered hemodialysis treatment time. Hemodial Int 2006, 10(4):346-350.
123. Heidenheim A.P., Muirhead N., Moist L., et al. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003, 42:36-41.
124. Lindsay R.M., Leitch R., Heidenheim A.P., et al. The London Daily/Nocturnal Hemodialysis Study-study design, morbidity, and mortality results. Am J Kidney Dis 2003, 42:5-12.
125. Gotch F.A., Levin N.W. Daily dialysis: the long and the short of it. Blood Purif 2003, 21(4-5):271-281.
126. Toussaint N.D. Review: differences in prescription between conventional and alternative haemodialysis. Nephrology (Carlton) 2010, 15(4):399-405.
127. Leypoldt J.K., Jaber B.L., Zimmerman D.L. Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 2004, 17(2):142-145.
128. Depner T.A., Gotch F.A., Port F.K., et al. How will the results of the HEMO study impact dialysis practice?. Semin Dial 2003, 16:8-21.
129. Casino F.G., Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996, 11:1574-1581.
130. Casino F.G., Marshall M.R. Simple and accurate quantification of dialysis in acute renal failure patients during either urea non-steady state or treatment with irregular or continuous schedules. Nephrol Dial Transplant 2004, 19:1454-1466.
131. Kanagasundaram N.S., Greene T., Larive A.B., et al. Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure. Kidney Int 2003, 64:2298-2310.
132. Debowska M., Lindholm B., Waniewski J. Adequacy indices for dialysis in acute renal failure: kinetic modeling. Artif Organs 2010, 34(5):412-419.
133. Daugirdas J.T., Levin N.W., Kotanko P., et al. Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area. Semin Dial 2008, 21(5):377-384.